SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-21-064019
Filing Date
2021-05-10
Accepted
2021-05-10 17:20:42
Documents
5
Effectiveness Date
2021-05-10

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2115779d2_s8.htm S-8 87043
2 EXHIBIT 5.1 tm2115779d2_ex5-1.htm EX-5.1 7197
3 EXHIBIT 23.1 tm2115779d2_ex23-1.htm EX-23.1 2414
4 EXHIBIT 99.1 tm2115779d2_ex99-1.htm EX-99.1 24250
5 GRAPHIC tm2115779d2_ex5-1img001.jpg GRAPHIC 3869
  Complete submission text file 0001104659-21-064019.txt   127467
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-255975 | Film No.: 21908534
SIC: 2834 Pharmaceutical Preparations